Search

Bob E Sherwood

from Wood, SD
Age ~77
Get Report
Also known as:
Bob Dr Sherwood, Bob E Kindell, Robert E Sherwood
Phone and address:
28749 261St St, Bad Nation, SD 57585
(605) 452-3262
Related to:
Jessica J Drelles, 41James Murphy, 84Suzanne Murphy, 48James Murphy, 58
Connected to:
Adelyn M Sherwood, 40Aimee Sherwood, 40Alaina Sherwood, 35Aldous V Sherwood, 36Alexis C Sherwood, 28Alissa Sherwood, 124April M Sherwood, 57Betty D Sherwood, 88Bobby J Sherwood, 65Brant D Sherwood, 34

Bob Sherwood Phones & Addresses

  • 28749 261St St, Wood, SD 57585 (605) 452-3262
  • Pierre, SD
  • Columbus, OH
  • Denver, CO
  • 5233 Route 44, Amenia, NY 12501
  • Franklin, OH

Business Records

Name / Title
Company / Classification
Phones & Addresses
Bob Sherwood
General Manager
City of Miami
Steet Department · Fire Protection · Executive Office · Legislative Body · National Security · Regulation/Administrative Utilities · Public Safety Office · Police Protection
(918) 542-6685, (918) 541-2321, (918) 541-2205, (918) 542-5585
Bob E. Sherwood
Purchasing Vice President
Jrs Pharma Lp
Mfg Pharmaceutical Preparations
2981 Rte 22, Patterson, NY 12563
(845) 878-8356, (845) 878-3414, (845) 878-8300, (845) 878-3484

Publications

Isbn (Books And Publications)

Hold Everything

View page
Author

Bob Sherwood

ISBN #

0932384196

Us Patents

Pharmaceutical Excipient Having Improved Compressibility

View page
US Patent:
6358533, Mar 19, 2002
Filed:
Jan 4, 2001
Appl. No.:
09/754760
Inventors:
Bob E. Sherwood - Amenia NY
John H. Staniforth - Bath, GB
Edward A. Hunter - Glenham NY
Assignee:
Edward Mendell, Co., Inc. - Patterson NY
International Classification:
A61K 914
US Classification:
424494, 424489, 424495, 424469, 424470, 428402
Abstract:
A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0. 1% to about 20% silicon dioxide particles, by weight of the microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide.

Directly Compressible High Load Acetaminophen Formulations

View page
US Patent:
6391337, May 21, 2002
Filed:
Mar 2, 2001
Appl. No.:
09/798755
Inventors:
Edward A. Hunter - Glenham NY
Bob E. Sherwood - Amenia NY
Joseph A. Zeleznik - New Paltz NY
Assignee:
Edward Mendell Co., Inc. - Patterson NY
International Classification:
A61K 920
US Classification:
424474, 424489, 424490, 424464, 424465, 424497
Abstract:
Direct compressed solid pharmaceutical dosage forms containing: a) from about 40 to about 95% by weight acetaminophen; b) from about 1 to about 60% by weight of a direct compression vehicle comprising microcrystalline cellulose; and c) from about 0. 01 to about 4. 0% by weight of a pharmaceutically-acceptable lubricant are disclosed. The acetaminophen and direct compression vehicle are combined under high shear conditions which are sufficient to transform acetaminophen and direct compression vehicle into a homogenous granulate without degradation. In preferred aspects of the invention, the lubricant is also combined with the acetaminophen and direct compression vehicle under high shear conditions. Methods of preparing the directly compressed solid pharmaceutical dosage forms and methods of treatment with the dosage forms are also disclosed. The methods are particularly well suited for preparing directly compressed dosage forms containing high load (i. e.

Process For Preparing A Directly Compressible Solid Dosage Form Containing Microcrystalline Cellulose

View page
US Patent:
6395303, May 28, 2002
Filed:
Jun 4, 1997
Appl. No.:
08/868745
Inventors:
John N. Staniforth - Bath, GB
Bob E. Sherwood - Amenia NY
Edward A. Hunter - Glenham NY
Clifford M. Davidson - Morganville NJ
Assignee:
Edward Mendell Co., Inc. - Patterson NY
International Classification:
A61K 914
US Classification:
424499, 424464, 424468, 424480, 424486, 424487, 424488, 424494, 424489
Abstract:
The present invention provides an improved process for the preparation of a agglomerated solid dosage form, comprising preparing an aqueous slurry of microcrystalline cellulose and a microcrystalline cellulose compressibility augmenting agent and an active agent. The augmenting agent is capable of physically restricting the proximity of the interface between adjacent cellulose surfaces and/or inhibiting interactions between adjacent cellulose surfaces, for example, via the creation of a hydrophobic boundary at cellulose surfaces. The resulting aqueous slurry is dried in a manner which inhibits quasi-hornification, thereby obtaining an agglomerated material which is directly compressible into a solid dosage form.

Pharmaceutical Excipient Having Improved Compressibility

View page
US Patent:
6471994, Oct 29, 2002
Filed:
Aug 27, 1999
Appl. No.:
09/384130
Inventors:
John N. Staniforth - Bath, GB
Bob E. Sherwood - Amenia NY
Edward A. Hunter - Cadosia NY
Assignee:
Edward Mendell Co., Inc. - Patterson NY
International Classification:
A16K 914
US Classification:
424489, 424490, 424499, 424464, 264112, 264115
Abstract:
A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0. 1% to about 20% silicon dioxide particles, by weight of microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide. An extra low moisture excipient is provided which exhibits improved compressibility as compared to conventional microcrystalline cellulose, while providing a moisture content of from about 0. 5 to 2. 5% LOD, preferably between about 0. 5 and about 1.

Pharmaceutical Excipient Having Improved Compressibility

View page
US Patent:
6521261, Feb 18, 2003
Filed:
Oct 16, 2001
Appl. No.:
09/981319
Inventors:
Bob E. Sherwood - Amenia NY
John H. Staniforth - Bath, GB
Edward A. Hunter - Glenham NY
Assignee:
Edward Mendell Co., Inc. - Patterson NY
International Classification:
A61K 914
US Classification:
424494, 424400, 424489, 424495, 424469, 424470
Abstract:
A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0. 1% to about 20% silicon dioxide particles, by weight of the microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide.

Pharmaceutical Excipient Having Improved Compressibility

View page
US Patent:
6746693, Jun 8, 2004
Filed:
Oct 8, 2002
Appl. No.:
10/266518
Inventors:
John N. Staniforth - Bath, GB
Bob E. Sherwood - Amenia NY
Edward A. Hunter - Cadosia NY
Assignee:
J. Rettenmaier Soehne GmbH + Co. KG - Rosenberg
International Classification:
A61K 914
US Classification:
424489, 424464, 424465, 424479, 424480, 424490, 424499, 264112, 264115
Abstract:
A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0. 1% to about 20% silicon dioxide particles, by weight of microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide. An extra low moisture excipient is provided which exhibits improved compressibility as compared to conventional microcrystalline cellulose, while providing a moisture content of of from about 0. 5 to 2. 5% LOD, preferably between about 0. 5 and about 1.

Pharmaceutical Excipient Having Improved Compressibility

View page
US Patent:
6858231, Feb 22, 2005
Filed:
Jan 8, 2003
Appl. No.:
10/338361
Inventors:
Bob E. Sherwood - Amenia NY, US
John H. Staniforth - Bath, GB
Edward A. Hunter - Glenham NY, US
Assignee:
J. Rettenmaier & Soehne GmbH + Co. KG - Rosenberg
International Classification:
A61K009/14
US Classification:
424494, 424400, 424464, 424465, 424489, 424490, 10615451
Abstract:
A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0. 1% to about 20% silicon dioxide particles, by weight of the microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide.

Process For Preparing A Directly Compressible Solid Dosage Form Containing Microcrystalline Cellulose

View page
US Patent:
6866867, Mar 15, 2005
Filed:
Dec 13, 2001
Appl. No.:
10/015538
Inventors:
John N. Staniforth - Bath, GB
Bob E. Sherwood - Amenia NY, US
Edward A. Hunter - Glenham NY, US
Clifford M. Davidson - Morganville NJ, US
Assignee:
J. Rettenmaier & Soehne GmbH + Co. KG - Rosenberg
International Classification:
A61K009/14
A61K009/22
A61K009/28
US Classification:
424499, 424464, 424465, 424468, 424474, 424489
Abstract:
The present invention provides an improved process for the preparation of a agglomerated solid dosage form, comprising: (1) preparing an aqueous slurry of (a) microcrystalline cellulose; (b) a microcrystalline cellulose compressibility augmenting agent which (i) physically restricts the proximity of the interface between adjacent cellulose surfaces; (ii) inhibits interactions between adjacent cellulose surfaces, for example, via the creation of a hydrophobic boundary at cellulose surfaces; or (iii) accomplishes both (i) and (ii) above; and (c) an active agent; (2) thereafter drying the resultant aqueous slurry in a manner which inhibits quasi-hornification, thereby obtaining an agglomerated material which is directly compressible into a solid dosage form.
Control profile
Bob E Sherwood from Wood, SD, age ~77 Get Report